Shannon K Crowley1, Susan S Girdler. 1. Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7175, USA.
Abstract
RATIONALE: A robust epidemiological literature suggests an association between chronic stress and the development of affective disorders. However, the precise biological underpinnings of this relationship remain elusive. Central to the human response and adaptation to stress, activation and inhibition of the hypothalamic pituitary adrenal (HPA) axis involves a multi-level, multi-system, neurobiological stress response which is as comprehensive in its complexity as it is precarious. Dysregulation in this complex system has implications for human stress related illness. OBJECTIVES: The pioneering research of Robert Purdy and colleagues has laid the groundwork for advancing our understanding of HPA axis regulation by stress-derived steroid hormones and their neuroactive metabolites (termed neurosteroids), which are potent allosteric modulators of GABAA receptor function in the central nervous system. This review will describe what is known about neurosteroid modulation of the HPA axis in response to both acute and chronic stress, particularly with respect to the current state of our knowledge of this process in humans. RESULTS: Implications of this research to the development of human stress-related illness are discussed in the context of two human stress-related psychiatric disorders - major depressive disorder and premenstrual dysphoric disorder. CONCLUSIONS: Neurosteroid-mediated HPA axis dysregulation is a potential pathophysiologic mechanism which may cross traditional psychiatric diagnostic classifications. Future research directions are identified.
RATIONALE: A robust epidemiological literature suggests an association between chronic stress and the development of affective disorders. However, the precise biological underpinnings of this relationship remain elusive. Central to the human response and adaptation to stress, activation and inhibition of the hypothalamic pituitary adrenal (HPA) axis involves a multi-level, multi-system, neurobiological stress response which is as comprehensive in its complexity as it is precarious. Dysregulation in this complex system has implications for humanstress related illness. OBJECTIVES: The pioneering research of Robert Purdy and colleagues has laid the groundwork for advancing our understanding of HPA axis regulation by stress-derived steroid hormones and their neuroactive metabolites (termed neurosteroids), which are potent allosteric modulators of GABAA receptor function in the central nervous system. This review will describe what is known about neurosteroid modulation of the HPA axis in response to both acute and chronic stress, particularly with respect to the current state of our knowledge of this process in humans. RESULTS: Implications of this research to the development of humanstress-related illness are discussed in the context of two humanstress-related psychiatric disorders - major depressive disorder and premenstrual dysphoric disorder. CONCLUSIONS: Neurosteroid-mediated HPA axis dysregulation is a potential pathophysiologic mechanism which may cross traditional psychiatric diagnostic classifications. Future research directions are identified.
Authors: O M Wolkowitz; V I Reus; A Keebler; N Nelson; M Friedland; L Brizendine; E Roberts Journal: Am J Psychiatry Date: 1999-04 Impact factor: 18.112
Authors: Peter J Schmidt; Robert C Daly; Miki Bloch; Mark J Smith; Merry A Danaceau; Linda Simpson St Clair; Jean H Murphy; Nazli Haq; David R Rubinow Journal: Arch Gen Psychiatry Date: 2005-02
Authors: Rael D Strous; Rachel Maayan; Raya Lapidus; Rafael Stryjer; Michal Lustig; Moshe Kotler; Abraham Weizman Journal: Arch Gen Psychiatry Date: 2003-02
Authors: Jennifer L Gordon; Susan S Girdler; Samantha E Meltzer-Brody; Catherine S Stika; Rebecca C Thurston; Crystal T Clark; Beth A Prairie; Eydie Moses-Kolko; Hadine Joffe; Katherine L Wisner Journal: Am J Psychiatry Date: 2015-01-13 Impact factor: 18.112
Authors: Matheus Marcon; Ana P Herrmann; Ricieri Mocelin; Cassiano L Rambo; Gessi Koakoski; Murilo S Abreu; Greicy M M Conterato; Luiza W Kist; Maurício R Bogo; Leila Zanatta; Leonardo J G Barcellos; Angelo L Piato Journal: Psychopharmacology (Berl) Date: 2016-08-25 Impact factor: 4.530
Authors: Tory A Eisenlohr-Moul; David R Rubinow; Crystal E Schiller; Jacqueline L Johnson; Jane Leserman; Susan S Girdler Journal: Psychoneuroendocrinology Date: 2016-02-01 Impact factor: 4.905
Authors: Shannon K Crowley; Todd K O'Buckley; Crystal E Schiller; Alison Stuebe; A Leslie Morrow; Susan S Girdler Journal: Psychopharmacology (Berl) Date: 2016-02-09 Impact factor: 4.530
Authors: Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Shunyan Mo; Hien P Nguyen; Abby Svenson; Nina Jaitly; Janet E Hall; Bruce A Barton; Anthony J Rothschild; Scott A Shaffer Journal: Psychoneuroendocrinology Date: 2016-05-09 Impact factor: 4.905